Results of a randomized study comparing DTIC with TIC mustard in malignant melanoma
β Scribed by Mary E. Costanza; Larry Nathanson; William G. Costello; Janet Wolter; S. Fred Brunk; Jacob Colsky; Thomas Hall; Richard A. Oberfield; William Regelson
- Publisher
- John Wiley and Sons
- Year
- 1976
- Tongue
- English
- Weight
- 446 KB
- Volume
- 37
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The authors acknowledge the authorship of the following members of the Swedish Melanoma BACKGROUND. The traditional surgical treatment for primary malignant melanoma has often been a wide excision with a margin of about 5 cm. Since the risk of local recurrences is dependent on tumor thickness, thin
Eighteen patients with surgically incurable metastatic malignant melanoma were treated with a mixture of irradiated (15,000 rads) autologous tumors cells (1-2 X 10(8)) and BCG (Glaxo, 2-4.5 X 10(6) organisms), which was injected intradermally (in five divided doses) every 2 weeks (X5). Four of 18 (2